An experimental study using an animal model to assess the effects of AST-120 showed that rats treated with AST-120 had decreased levels of indoxyl sulfate in both the serum and urine and reduced expression of profibrotic genes, such as TGF-β1, ultimately slowing chronic renal failure [109]. The gene discussed is TGFB1; the disease is chronic kidney disease.